Literature DB >> 26027945

Differential molecular and cellular responses of GLP-1 secreting L-cells and pancreatic alpha cells to glucotoxicity and lipotoxicity.

Srividya Vasu1, R Charlotte Moffett2, Neville H McClenaghan2, Peter R Flatt2.   

Abstract

Knowledge of the effects of glucotoxic and lipotoxic environments on proglucagon producing intestinal L cells and pancreatic alpha cells is limited compared with pancreatic beta cells. This study compares the in vitro responses of these cell types to hyperglycaemia and hyperlipidaemia. Glucose (30 mM) and palmitate (0.5mM) reduced GLUTag and MIN6 cell viability while alpha TC1 cells were sensitive only to lipotoxicity. Consistent with this, Cat mRNA expression was substantially higher in GLUTag and alpha TC1 cells compared to MIN6 cells. Glucose and palmitate reduced GLUTag cell secretory function while hypersecretion of glucagon was apparent from alpha TC1 cells. Glucose exposure increased transcription of Cat and Sod2 in MIN6 and GLUTag cells respectively while it decreased transcription of Cat and Gpx1 in alpha TC1 cells. Palmitate increased transcription of Cat and Sod2 in all three cell lines. Upregulation of antioxidant enzyme expression by palmitate was accompanied by an increase in Nfkb1 transcription, indicative of activation of defence pathways. Lipotoxicity activated ER stress response, evident from increased Hspa4 mRNA level in GLUTag and MIN6 cells. Glucose and palmitate-induced DNA damage and apoptosis, with substantially smaller effects in alpha TC1 cells. Thus alpha cells are resistant to gluco- and lipotoxicity, partly reflecting higher expression of genes involved in antioxidant defence. In contrast, intestinal L cells, like beta cells, are prone to gluco- and lipotoxicity, possibly contributing to abnormalities of GLP-1 secretion in type 2 diabetes.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alpha cells; Beta cells; GLP-1; Glucotoxicity; L cells; Lipotoxicity

Mesh:

Substances:

Year:  2015        PMID: 26027945     DOI: 10.1016/j.yexcr.2015.05.022

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  11 in total

1.  Reduced islet function contributes to impaired glucose homeostasis in fructose-fed mice.

Authors:  Zeenat A Asghar; Andrew Cusumano; Zihan Yan; Maria S Remedi; Kelle H Moley
Journal:  Am J Physiol Endocrinol Metab       Date:  2016-12-27       Impact factor: 4.310

2.  Disrupted and Elevated Circadian Secretion of Glucagon-Like Peptide-1 in a Murine Model of Type 2 Diabetes.

Authors:  Andrew D Biancolin; Hyerin Jeong; Kimberly W Y Mak; Zixuan Yuan; Patricia L Brubaker
Journal:  Endocrinology       Date:  2022-09-01       Impact factor: 5.051

3.  Insulin regulates glucagon-like peptide-1 secretion by pancreatic alpha cells.

Authors:  Pan Liu; Jia Song; He Liu; Fei Yan; Tianyi He; Lingshu Wang; Huying Shen; Xinguo Hou; Li Chen
Journal:  Endocrine       Date:  2018-08-06       Impact factor: 3.633

4.  Effects of long-acting GIP, xenin and oxyntomodulin peptide analogues on alpha-cell transdifferentiation in insulin-deficient diabetic GluCreERT2;ROSA26-eYFP mice.

Authors:  Dipak Sarnobat; R Charlotte Moffett; Victor A Gault; Neil Tanday; Frank Reimann; Fiona M Gribble; Peter R Flatt; Nigel Irwin
Journal:  Peptides       Date:  2019-11-16       Impact factor: 3.750

5.  Glucotoxicity induces abnormal glucagon secretion through impaired insulin signaling in InR1G cells.

Authors:  Takashi Katsura; Dan Kawamori; Eri Aida; Taka-Aki Matsuoka; Iichiro Shimomura
Journal:  PLoS One       Date:  2017-04-20       Impact factor: 3.240

6.  Alpha TC1 and Beta-TC-6 genomic profiling uncovers both shared and distinct transcriptional regulatory features with their primary islet counterparts.

Authors:  Nathan Lawlor; Ahrim Youn; Romy Kursawe; Duygu Ucar; Michael L Stitzel
Journal:  Sci Rep       Date:  2017-09-20       Impact factor: 4.379

7.  The triterpenoid sapogenin (2α-OH-Protopanoxadiol) ameliorates metabolic syndrome via the intestinal FXR/GLP-1 axis through gut microbiota remodelling.

Authors:  Zhifu Xie; Haowen Jiang; Wei Liu; Xinwen Zhang; Dakai Chen; Shuimei Sun; Chendong Zhou; Jia Liu; Sheng Bao; Xiachang Wang; Yinan Zhang; Jia Li; Lihong Hu; Jingya Li
Journal:  Cell Death Dis       Date:  2020-09-17       Impact factor: 8.469

8.  Adipocyte-specific deletion of Tcf7l2 induces dysregulated lipid metabolism and impairs glucose tolerance in mice.

Authors:  Marie-Sophie Nguyen-Tu; Aida Martinez-Sanchez; Isabelle Leclerc; Guy A Rutter; Gabriela da Silva Xavier
Journal:  Diabetologia       Date:  2020-10-17       Impact factor: 10.122

9.  Benefits of Sustained Upregulated Unimolecular GLP-1 and CCK Receptor Signalling in Obesity-Diabetes.

Authors:  Neil Tanday; Andrew English; Ryan A Lafferty; Peter R Flatt; Nigel Irwin
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-14       Impact factor: 5.555

Review 10.  Inflammation Meets Metabolic Disease: Gut Feeling Mediated by GLP-1.

Authors:  Tamara Zietek; Eva Rath
Journal:  Front Immunol       Date:  2016-04-22       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.